| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.0M | -41.4% |
| Cost of Revenue | $3.1M | -67.2% |
| Gross Profit | $2.9M | +334.9% |
| R&D Expense | $58K | -77.3% |
| SG&A Expense | $2.7M | +22.7% |
| Operating Income | -$505K | +42.0% |
| Pre-tax Income | -$24.8M | -3126.0% |
| Income Tax | $5K | -40.6% |
| Net Income | -$24.8M | -1550.5% |
| EPS (Basic) | -$1.36 | -3300.0% |
| EPS (Diluted) | -$1.36 | -3300.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | — |
| Inventory | $1.1M | -69.9% |
| Current Assets | $11.1M | — |
| Total Assets | $11.2M | -38.1% |
| Current Liabilities | $687K | -60.8% |
| Total Liabilities | $746K | -57.4% |
| Stockholders' Equity | $10.4M | +697.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.6M | — |
| Investing Cash Flow | $16K | -100.0% |
| Financing Cash Flow | $12.2M | +134.3% |